![]() |
市场调查报告书
商品编码
1954590
全球眼科超音波市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Ophthalmic Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球眼科超音波市场规模为3.0373亿美元。预计该市场将从2026年的3.2519亿美元成长到2034年的5.7855亿美元,在预测期(2026-2034年)内复合年增长率(CAGR)为7.47%。北美地区引领全球眼科超音波市场,预计到2025年将占42.34%的市场占有率,这主要得益于其先进的医疗基础设施和眼部疾病盛行率的上升。
眼科超音波设备是一种专业的影像诊断系统,它利用高频声波来观察眼内结构,例如视网膜、玻璃体、前节和眼眶。该设备对于诊断青光眼、糖尿病视网膜病变、老年黄斑部病变、玻璃体出血和视网膜剥离等疾病至关重要。
市场驱动因素
眼部疾病盛行率上升
眼部疾病负担日益加重是推动市场成长的主要因素。根据2025年3月发布的数据,预计到2025年底,全球约有30.6%的成年人患有远视。在美国和欧洲,预计到2025年底,远视盛行率将分别达到37.2%和23.1%。
此外,美国疾病管制与预防中心(CDC)于2024年10月报告称,截至2022年,美国有420万人患有青光眼,其中150万人的视力受到影响。患者数量的增加推动了对早期、精准的诊断影像工具(例如眼科超音波系统)的需求。
市场限制因子
设备成本高等替代技术
儘管市场稳定成长,但设备价格高昂(5,500 美元至 20,000 美元不等),这构成了市场挑战。这限制了低收入和中等收入国家的普及。
此外,光学相干断层扫描 (OCT)、眼底成像和磁振造影 (MRI) 等替代成像技术的普及也加剧了竞争。例如,2024年6月,日本电产株式会社推出了RS-1,这是一款用于青光眼的OCT系统,具有先进的诊断功能,可以减少对传统超音波系统的依赖。
市场机会
医疗基础设施的扩张
新的眼科诊所和医院的开设创造了巨大的成长机会。2024年10月,雪梨眼科医院开设了Gadigal眼科诊所;2024年3月,Optegra眼科诊所在英国开业,进一步拓展了眼科医疗服务。
诸如由L.V. Prasad 眼科研究所进一步支持早期诊断,并在全球推广相关设备的使用。
市场趋势
技术创新与便携式设备
一个主要的市场趋势是便携式、技术先进的超音波设备的普及率不断提高。 2024 年 5 月,Quantel Medical 推出了 Pocket III 便携式超音波角膜厚度分析仪,进一步拓展了便携式诊断解决方案。
此外,3D 影像技术的应用也不断成长,从而提升了可视化效果和手术规划能力。 Sonomed Escalon 等公司正在推出整合式 3D 超音波系统,以提高诊断准确性。
依产品分类
设备细分市场凭藉着不断涌现的新产品和技术进步,引领市场发展。随着眼科手术中配件使用量的增加,配件市场也稳定成长。
依装置类型
便携式设备市场预计将实现最高成长,这得益于其便利性、易用性和成本效益。推车式系统在医院环境中持续成长,而手持式设备在门诊环境中也越来越受欢迎。
依成像类型
受可视化效果提升和诊断结果增强的推动,3D成像市场预计将在2034年之前保持最高的复合年增长率。 2D成像市场由于其价格实惠和广泛应用,仍占较大的市场占有率。
依最终使用者
由于新诊所数量的增加,眼科诊所预计将实现最高的复合年增长率。由于诊断程序量庞大,医院仍将是主要市场组成部分。
北美
预计到2025年,北美市场规模将达到1.2859亿美元,占42.34%的市占率。先进的医疗保健体系和较高的健康意识是该地区的优势。
欧洲
欧洲将占第二大市场规模,这得益于眼科诊所的扩张和强劲的医疗保健资金投入。
亚太地区
预计到2034年,亚太地区将以最高的复合年增长率成长,这主要得益于监管审批的增加和医疗保健投资的扩大。 2024年5月,ArcScan Insight 100获得中国国家药品监督管理局(NMPA)的批准,进一步推动了该地区的成长。
拉丁美洲、中东和非洲
由于眼科疾病宣传活动的增加和眼科疾病盛行率的上升,预计这些地区将保持稳定成长。
The global ophthalmic ultrasound market size was valued at USD 303.73 million in 2025. The market is projected to grow from USD 325.19 million in 2026 to USD 578.55 million by 2034, exhibiting a CAGR of 7.47% during the forecast period (2026-2034). North America dominated the global ophthalmic ultrasound market with a 42.34% market share in 2025, driven by advanced healthcare infrastructure and rising prevalence of eye disorders.
Ophthalmic ultrasound devices are specialized diagnostic imaging systems that use high-frequency sound waves to visualize internal eye structures such as the retina, vitreous humor, anterior segment, and orbit. These devices are essential for diagnosing conditions such as glaucoma, diabetic retinopathy, macular degeneration, vitreous hemorrhage, and retinal detachment.
Market Drivers
Growing Prevalence of Eye Disorders
The increasing burden of ophthalmic diseases is a primary driver of market growth. According to data published in March 2025, approximately 30.6% of adults globally are expected to suffer from hyperopia by the end of 2025. In America and Europe, hyperopia prevalence is projected to reach 37.2% and 23.1%, respectively, by the end of 2025.
Additionally, the CDC reported in October 2024 that 4.2 million people in the U.S. were living with glaucoma in 2022, including 1.5 million with vision-affecting glaucoma. The increasing patient population is fueling demand for early and accurate diagnostic imaging tools such as ophthalmic ultrasound systems.
Market Restraints
High Cost of Devices and Alternative Technologies
Despite steady growth, the market faces challenges due to the high cost of devices, ranging between USD 5,500 and USD 20,000. This limits adoption in low- and middle-income countries.
Moreover, the availability of alternative imaging technologies such as Optical Coherence Tomography (OCT), fundus imaging, and MRI presents competitive pressure. For instance, in June 2024, NIDEK CO., LTD. launched the RS-1 Glaucoma OCT system, offering advanced diagnostic capabilities, which may reduce reliance on traditional ultrasound systems.
Market Opportunities
Expansion of Healthcare Infrastructure
The opening of new ophthalmic clinics and hospitals is creating significant growth opportunities. In October 2024, Sydney Eye Hospital launched the Gadigal Eye Clinic, and in March 2024, Optegra Eye Clinic opened in England to enhance ophthalmic services.
Awareness initiatives such as Glaucoma Awareness Week (March 8-16, 2025) organized by L.V. Prasad Eye Institute are further supporting early diagnosis, boosting device utilization globally.
Market Trends
Technological Advancements and Portable Devices
A major market trend is the increasing adoption of portable and technologically advanced ultrasound devices. In May 2024, Quantel Medical launched Pocket III, a handheld ultrasound pachymeter, expanding portable diagnostic solutions.
Additionally, the adoption of 3D imaging technology is rising, offering improved visualization and surgical planning capabilities. Companies such as Sonomed Escalon are introducing integrated 3D ultrasound systems to enhance diagnostic precision.
By Product
The device segment dominates the market due to increasing product launches and technological advancements. Accessories are also growing steadily due to increased usage during ophthalmic surgeries.
By Device Type
The portable segment is expected to witness the highest growth due to convenience, accessibility, and cost-effectiveness. Cart-based systems continue to grow in hospital settings, while hand-held devices are gaining popularity for outpatient care.
By Imaging Type
The 3D imaging segment is projected to grow at the highest CAGR through 2034, driven by enhanced visualization and improved diagnostic outcomes. The 2D imaging segment continues to hold a significant share due to affordability and widespread use.
By End-user
Ophthalmic clinics are expected to grow at the highest CAGR due to increasing clinic openings. Hospitals remain a major segment due to the high volume of diagnostic procedures.
North America
North America generated USD 128.59 million in 2025 and held a 42.34% market share. The region benefits from advanced healthcare systems and high awareness levels.
Europe
Europe represents the second-largest market, supported by expanding ophthalmology clinics and strong healthcare funding.
Asia Pacific
Asia Pacific is projected to grow at the highest CAGR through 2034 due to increasing regulatory approvals and healthcare investments. In May 2024, ArcScan Insight 100 received NMPA approval in China, strengthening regional growth.
Latin America & Middle East & Africa
These regions are expected to grow steadily due to increasing awareness campaigns and rising ocular disease prevalence.
Competitive Landscape
Key players operating in the global ophthalmic ultrasound market include:
Companies are focusing on partnerships, facility expansions, and product innovations. For instance, in February 2025, Keeler launched a new manufacturing facility in Shanghai, China, expanding its global footprint.
Conclusion
The global ophthalmic ultrasound market, valued at USD 303.73 million in 2025, is set to reach USD 578.55 million by 2034, growing at a CAGR of 7.47%. Growth is primarily driven by the rising prevalence of eye disorders, technological advancements, increasing healthcare infrastructure, and expanding awareness initiatives. While high device costs and alternative diagnostic technologies pose challenges, ongoing innovation, portable device adoption, and regional expansion strategies are expected to sustain steady market growth through 2034.
Segmentation By Product
By Device Type
By Imaging Type
By End-user
By Region